Three Stocks for Your 'Forever Portfolio'

Two companies have the cash, the current investor base and the technology to be worth looking at for a "Forever Portfolio."

Venus Medical Technologies(VNUS Quote) specializes in non-invasive, outpatient treatment of varicose veins. About 25 million people in the U.S. suffer from varicose veins, and another 40 million in Western Europe. In 2006 1.2 million sought treatment for the condition. The reason so few seek treatment is that it often involves painful invasive surgery (removing the vein in question) with potentially many side effects.

The Venus procedure is to give the patient a radio-frequency, or RF, generator that provides the power and monitoring for a disposable catheter that heats the vein. The disposable catheters generate recurring revenue for the company. Of the estimated 65 million people who have varicose vein conditions, only about 60,000, as of the time of this writing, have used the company's procedure for treatment.

Venus' revenue has gone up every year since it started selling its product in 1999, and the company has been profitable since the fourth quarter of 2003.

Syneron Medical(ELOS Quote) is another company in the sector.

Syneron also uses RF energy to deliver heat to layers of the skin below the epidermis, avoiding the burning associated with other skin treatments. Syneron's device can constantly monitor the level of heat and energy it is applying to an area and adjust accordingly. These treatments have been used for wrinkles, leg veins, acne, cellulite and a host of other cosmetic solutions. Revenue and income have gone up every year since 2001.